Sugamadeks Teva 100 mg/ml otopina za injekciju
| Name | Sugamadeks Teva 100 mg/ml otopina za injekciju |
|---|---|
| Marketing Authorisation Number | HR-H-336447679 |
| Active Substance | sugamadeksnatrij |
| Composition | 1 ml otopine sadrži 100 mg sugamadeksa (u obliku sugamadeksnatrija) |
| Pharmaceutical Form | otopina za injekciju |
| Manufacturer | Pliva Hrvatska d.o.o., Zagreb, Hrvatska |
| Marketing Authorisation Holder | Teva B.V., Swensweg 5, Haarlem, Nizozemska |
| Marketing Authorisation Date | 01.02.2022 |
| MA Period of Validity | 01.02.2027 |
| Classification Number | UP/I-530-09/20-01/250 |
| Registration Number | 381-12-01/70-22-04 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | V03AB35 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
